dQ&A Patient
Voice 2025
What's the Story?
dQ&A is announcing the availability of new data collected this quarter from ten thousand people with diabetes in the USA, Canada and seven EU countries.
This data unlocks key trends, reveals market dynamics and paints a compelling picture of real-world patient attitudes and behaviors.
If your end-customer is someone with diabetes, then contact us to discuss how these insights can drive your business forward.
Sneak Peek - United States
Ketone testing is in the news as a way to avoid ER visits for DKA (whatever the root cause). It’s clear that patients should have a means of testing and be familiar with how ketone testing works.
Ketone Test Kit Ownership
Data from n=6,021 people with diabetes shows that most type 2s and nearly half of type 1s don’t own a ketone testing kit. In contrast, parents of type 1 kids had made the investment.
Our respondents mostly tested their ketones when their blood glucose was high, when they felt ill, or had GI symptoms.
Confidence in Results
But worryingly, 62% of type 1s and 81% of type 2s who have ever owned a ketone test kit say that they don’t completely understand what the readings mean (and what they should do about it).
It seems that there is room for further education on this topic.
Sneak Peek – Europe
We asked n=2,872 people with diabetes in the UK, France, Germany, Spain, Italy, Netherlands and Sweden the following question about their CGM device:
"Imagine your healthcare provider has recommended you use the following devices. One device option features artificial intelligence (AI) that can help you analyze your diabetes data and provide personalized recommendations and the other does not.
Assuming that both products are otherwise virtually indistinguishable in their form, function, and cost, which would you prefer?"
Between half and two-thirds were welcoming of AI, demonstrating trust for the technology. There was a group of 13%-17% who did not want AI. It’s notable that the results were similar across type 1 and type 2, age group and gender (although the differences are statistically significant given the large sample size).
Confidence in Results
We asked similar questions for pumps and blood glucose meters as well as CGM (for those patients already using the devices).
The more sophisticated the device, the more respondents were interested in AI support, although as before, type 2 patients lagged behind type 1.
Continue the Conversation
This data snack is only a small portion of the insights and analysis offered by this Data Service. Contact us to discuss the results from dQ&A Patient Voice Q2 2025 update.
Do You Have Questions
About Diabetes Research?
This research excerpt is just the tip of the iceberg. dQ&A has decades of experience across the United States, Canada, and Europe. If you drive critical diabetes research decisions in your organization, dQ&A is the diabetes insight partner that can get the answers you need.
